Amneal Pharmaceuticals, Inc. (AMRX)
13.20
-0.52
(-3.79%)
USD |
NASDAQ |
May 08, 16:00
13.20
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Shareholders Equity (Quarterly) : -45.41M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.66B |
| Pfizer Inc. | 90.10B |
| Crinetics Pharmaceuticals, Inc. | 1.281B |
| Prestige Consumer Healthcare, Inc. | 1.829B |
| Amphastar Pharmaceuticals, Inc. | 773.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.540B |
| Total Liabilities (Quarterly) | 3.500B |
| Debt to Equity Ratio | -59.38 |
| Current Ratio | 2.470 |
| Net Debt Paydown Yield | -0.52% |